Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany

Pharmacopsychiatry

Volumn 43, Issue 6, 2010, Pages 210-215

  Moller H J ^a,d   Schnitker, J ^b   Flurenbrock W ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute for Applied Statistics   (Germany)

^c Lundbeck GmbH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN DERIVATIVE; DIGITALIS; ESCITALOPRAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRANQUILIZER;

AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GERMANY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; NAUSEA; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; PSYCHOTHERAPY; REMISSION; RESTLESSNESS; SCORING SYSTEM; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; CITALOPRAM; DEMENTIA; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HUMANS; MALE; MOOD DISORDERS; OUTPATIENTS; POLYPHARMACY; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 77956423912     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1254152     Document Type: Article

References (13)

1. Bech P, Andersen HF, Wade A. Effective dose of escitalopram in moderate versus severe DSM-IV major depression. Pharmacopsychiatry 2006 39 128-134
2. Bech P, Tanghoj P, Cialdella P, etal. Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Int J Neuropsychopharmacol 2004 7 238-290
3. Gorwood P, Weiller E, Lemming O, etal. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007 15 581-593
4. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Dept Health, Education, and Welfare publication (ADM) 1976 76-338 Rockville, MD, National Institute of Mental Health
5. Kennedy SH, Lam RW, Morris B, CANMAT Depression Work Group. Clinical guidelines for depressive disorders. Summary of recommendations relevant to family physicians. Can Fam Physician 2003 49 489-491
6. Klysner R, Bent-Hansen J, Hansen HL, etal. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002 181 29-35
7. Möller HJ, Langer S, Schmau M. Escitalopram in clinical practice: Results of an open-label trial in outpatients with depression in a naturalistic setting in Germany. Pharmacopsychiatry 2007 40 53-57
8. Möller HJ, Schnitker J. [Prospective study using a modified Montgomery-Asberg depression scale]. Nervenarzt 2007 DOI 10.1007/s00115-007- 2278-0 (Pubitemid 47365995)
9. Möller HJ. Isnt the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch etal. 2008. Eur Arch Psychiatry Clin Neurosci 2008 258 451-455
10. Möller HJ, Baldwin D, Goodwin G, etal. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci 2008 258 3-23
11. Montgomery S, Möller HJ. Is the significant superiority of escitalopram compared to other antidepressants clinically relevant? Int Clin Psychopharmacol 2009 24 111-118
12. Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 2008 16 558-567
13. Trivedi MH, Rush AJ, Wisniewski SR. et al STAR*D Study Team Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006 163 28-40